Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06121986 · ClinicalTrials.gov registry record · NA

A Scalable Nutrition Adherence Intervention

A NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by Florida State University.

Active
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT06121986 is a NA study of Alzheimer Disease and Mild Cognitive Impairment that is active but no longer recruiting, run by Florida State University. The registered enrollment target is 61 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06121986, a NA study of Alzheimer Disease and Mild Cognitive Impairment, is active but no longer recruiting, sponsored by Florida State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

Objective 1: To scale-up the nutrition adherence intervention for testing in racially diverse rural communities in North Florida. The investigators hypothesize that: 1\. The protocol will produce at least 75% of participants obtaining measurable levels of urine ketones (e.g., good adherence) in the Modified Mediterranean-Ketogenic diet (MMKD) group and an average score of \>6 on the MEDAS questionnaire in the Mediterranean group during the 10-week program. Further, we hypothesize that the use of ongoing monthly support groups will bolster long-term adherence. Objective 2: To evaluate the effects of adherence to Mediterranean versus MMKD on novel gut-brain axis markers of Alzheimer's disease pathogenesis in individuals with mild cognitive impairment compared to cognitively normal older adults. The investigators hypothesize that individuals with mild cognitive impairment will: 1. Have greater evidence of gut dysbiosis at baseline than cognitively normal controls and 2. Will demonstrate greater increases in beneficial gut microbial metabolites in response to adherence to Mediterranean-Ketogenic nutrition and the Mediterranean diet compared to CN controls.

Conditions Studied

Alzheimer Disease Mild Cognitive Impairment Adherence

Interventions

  • BEHAVIORAL Improving Cognitive Aging through Nutrition (ICAN) Adherence Program
  • BEHAVIORAL Improving Cognitive Aging through Nutrition, Mediterranean diet

Study Locations (1)

Florida

  • 2010 Levy Ave - Center for Translational Behavioral Science - Tallahassee

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2023-11-30
Est. Completion 2026-05
Phase NA

Sponsor

Florida State University

219 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06121986

The ClinicalTrials.gov registry entry for NCT06121986 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Improving Cognitive Aging through Nutrition (ICAN) Adherence Program is the first listed.

NCT06121986 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06121986 about?

NCT06121986 is a clinical study titled "A Scalable Nutrition Adherence Intervention". Objective 1: To scale-up the nutrition adherence intervention for testing in racially diverse rural communities in North Florida. The investigators hypothesize that: 1\. The protocol will produce at least 75% of participants obtaining measurable levels of urine ketones (e.g., good adherence) in th...

What is the current status of trial NCT06121986?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 61 participants. The study started on 2023-11-30. Estimated completion is 2026-05.

What conditions does trial NCT06121986 study?

This clinical trial studies the following conditions: Alzheimer Disease, Mild Cognitive Impairment, Adherence.

What interventions are being tested in trial NCT06121986?

The interventions under investigation include: Improving Cognitive Aging through Nutrition (ICAN) Adherence Program (BEHAVIORAL), Improving Cognitive Aging through Nutrition, Mediterranean diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT06121986?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06121986 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Mild Cognitive Impairment

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.